R. Rulach

发表

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions.

J. Hicks, P. McLoone, S. Harrow, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.

M. Dempsey, S. Schipani, D. Grose, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.

M. Dempsey, S. Schipani, D. Grose, 2019, Oral oncology.

Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck.

S. Schipani, D. Grose, S. Kean, 2019, The British journal of oral & maxillofacial surgery.

TITLE: Radiotherapy induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease oral spray versus placebo in head and neck cancer patients Vs in xerostomia

S. Schipani, D. Grose, B. Caldwell, 2018 .

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

C. Hiley, C. Faivre-Finn, K. Franks, 2020, Clinical Oncology.

Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma

K. Kurian, R. Rulach, Natasha Lakin, 2017, Front. Oncol..

Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.

M. Dempsey, S. Schipani, D. Grose, 2022, Oral oncology.

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits.

G. Hanna, K. Franks, S. Harrow, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pancreatic cancer genomics: where can the science take us?

S. Grimmond, D. Chang, N. Jamieson, 2015, Clinical genetics.

UK Training in Clinical Oncology: The Trainees' Viewpoint.

A. Macnair, R. Rulach, F. Smith, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer

D. Gomez, D. de Ruysscher, A. Louie, 2021, Advances in radiation oncology.

Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer

B. Venugopal, J. Russell, A. Sadoyze, 2018, BJU international.

382P The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: Final results from a phase I study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma (GBM)

R. Plummer, H. Lane, I. Vivanco, 2020 .

Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours

R. Plummer, H. Lane, N. Tunariu, 2020, British Journal of Cancer.

P-080Incidence of thrombo-embolism (TE) during neo-adjuvant chemotherapy in patients (pts) with oesophago-gastric adenocarcinoma (OGC): implications for surgery and survival

J. Graham, D. Grose, G. Fullarton, 2016 .

Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion

N. Steele, R. Rulach, S. Ansel, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma.

S. Schipani, D. Grose, H. Dyab, 2023, Clinical oncology (Royal College of Radiologists (Great Britain)).